Literature DB >> 6884709

Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.

C H Ginsburg, J T Dambrauskas, K A Ault, Z M Falchuk.   

Abstract

The natural killer cell lymphocyte may represent an important element in immune defense. Since host defense may be abnormal in patients with inflammatory bowel disease, we assessed natural killer cell function in 34 patients with ulcerative colitis and Crohn's disease. Lymphocytes from 31 of 34 patients (91%) exhibited decreased natural killer cell activity (mean cytotoxicity +/- SEM was 25% +/- 7.5% of the mean normal values, p less than 0.01). Disease activity, type of disease, and steroid therapy had no influence on these values. None of the 10 age-matched disease controls with other intestinal inflammatory conditions had natural killer cell activity outside the normal range. The numbers of circulating killer cells present in patients with impaired activity were quantified using a cytofluorometric detection system. All patients tested had normal numbers of cells binding nonaggregated immunoglobulin G (Fc receptor positive) despite decreased natural killer cell activity. It appears that by using this cytofluorometric detection technique, decreased natural killer cell activity is not the consequence of diminished numbers of natural killer cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884709

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.

Authors:  L Manzano; M Alvarez-Mon; L Abreu; J Antonio Vargas; E de la Morena; F Corugedo; A Duràntez
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Authors:  T Kawase; K Kusugami; H Matsunaga; T Matsuura; K Morise
Journal:  Gastroenterol Jpn       Date:  1990-10

3.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

4.  Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.

Authors:  I Florentin; D Nolibe; J P Giroud
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

5.  Effects of nutritional therapy on chemiluminescence in Crohn's disease.

Authors:  N Okabe; K Maeda; M Okada; M Ueki; T Sakurai; T Matsui; T Yao
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

Review 6.  A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia.

Authors:  K Akahoshi; Y Miyata; M Hashimoto; S Koga; Y Chijiiwa; T Misawa; E Suematsu; J Nishimura; H Nawata
Journal:  Gastroenterol Jpn       Date:  1992-04

7.  Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

Authors:  M N Aparicio-Pagés; H W Verspaget; J C Hafkenscheid; G E Crama-Bohbouth; A S Peña; I T Weterman; H W Lamers
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

8.  Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin.

Authors:  M A Castany; H H Nguyen; M Pospísil; P Fric; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 9.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

10.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.